Medifocus Granted New US Patent for Thermoactivated Release Method Medifocus Inc. (TSXV:MFS,OTCQX:MDFZF) was issued a new patent by the United States Patent and Trademark Office: �Apparatus and Method for Pre-Conditioning/Fixation and Treatment of Disease with Heat Activation/Release with Thermoactivated Drugs and Gene Products� authored by John Mon, COO for Medifocus.
As quoted in the press release:
The Title of the patent is �Apparatus and Method for Pre-Conditioning/Fixation and Treatment of Disease with Heat Activation/Release with Thermoactivated Drugs and Gene Products.� The author of this patent is John Mon, COO for Medifocus. John Mon stated, �This patent, along with the other recently issued patents, allows Medifocus to partner up with other bio-tech companies in helping to develop and commercialize targeted thermoactivated/released drugs and gene products which, in our opinion, is the future of medicine.�